Search - tctmd.com

Displaying 81 - 100 of 138

Sort: Relevancy | Date

Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis

News Conference News AHA 2018

Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis

November 19, 2018

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

October 18, 2018

New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk

News Daily News

New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk

Yael L. Maxwell

October 16, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

October 04, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

VTE Risk Higher in Surgical Patients Who Get Transfusions

News Daily News

VTE Risk Higher in Surgical Patients Who Get Transfusions

June 13, 2018

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

News Daily News

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

June 11, 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

News Conference News ACC 2018

Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis

March 12, 2018

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

News Daily News

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

January 23, 2018

Shifts in Stroke Score Over Time Help Hone Risk Prediction

News Daily News

Shifts in Stroke Score Over Time Help Hone Risk Prediction

January 10, 2018

Live From Denver: TCT 2017, Day Four

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

November 02, 2017

Statins and Diabetes: Causal Link Reinforced in New Analysis

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

Infective Endocarditis Guidelines: The More the Merrier? Maybe Not

News Daily News

Infective Endocarditis Guidelines: The More the Merrier? Maybe Not

August 18, 2017

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

News Daily News

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

Yael L. Maxwell

May 10, 2017

More Conservative Antibiotic Prophylaxis for Infective Endocarditis Seems Safe, Appropriate

News Daily News

More Conservative Antibiotic Prophylaxis for Infective Endocarditis Seems Safe, Appropriate

April 28, 2017

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

March 15, 2017

Thromboembolic Prophylaxis in Atrial Fibrillation

Presentation SIF 2017

Thromboembolic Prophylaxis in Atrial Fibrillation

Presenter: Samir Kapadia

March 09, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.